Genetics

This study examines how NLRC5 may function as a central regulator of microglial PANoptosis in multiple sclerosis, linking epigenetic regulation, proteomic signaling, and inflammatory cell death into a unified disease mechanism. By integrating EAE microglial transcriptomics, Mendelian randomization, methylation analysis, and in vitro validation, the authors identify NLRC5 as a hub associated with apoptotic and necroptotic mediators and show that inflammatory stimulation promotes assembly of an NLRC5-related PANoptosome complex in microglia. The findings suggest that NLRC5 may contribute to chronic neuroinflammation and could represent a promising, though still preliminary, therapeutic target in MS.